Recombinant CD37 (Naratuximab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects CD37 (Naratuximab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.
Catalog No. ABIN7538072
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CD37 (Naratuximab Biosimilar) antibody (ABIN7538072)
Target
CD37 (Naratuximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This CD37 (Naratuximab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Naratuximab Biosimilar – Anti-CD37 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD37 (Naratuximab Biosimilar)
-
Background
- Naratuximab is a humanized monoclonal antibody that binds CD37. Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine.
-
CAS-No
- 1622327-39-2
Target
-
You are here:
